Cargando…
CRISPR/Cas9 can mediate high-efficiency off-target mutations in mice in vivo
Autores principales: | Aryal, Neeraj K, Wasylishen, Amanda R, Lozano, Guillermina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204134/ https://www.ncbi.nlm.nih.gov/pubmed/30368519 http://dx.doi.org/10.1038/s41419-018-1146-0 |
Ejemplares similares
-
Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018) -
Loss of digestive organ expansion factor (Diexf) reveals an essential role during murine embryonic development that is independent of p53
por: Aryal, Neeraj K., et al.
Publicado: (2017) -
Pathogen detection in the CRISPR–Cas era
por: Sashital, Dipali G.
Publicado: (2018) -
Knocking out consumer concerns and regulator’s rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals
por: Wolter, Felix, et al.
Publicado: (2017) -
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
por: Han, Hua Alexander, et al.
Publicado: (2020)